![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Apo-propafenone
2. Arythmol
3. Baxarytmon
4. Cuxafenon
5. Fenoprain
6. Hydrochloride, Propafenone
7. Jutanorm
8. Nistaken
9. Norfenon
10. Pintoform
11. Prolecofen
12. Propafenon Al
13. Propafenon Hexal
14. Propafenon Minden
15. Propafenone
16. Propafenone Hydrochloride, (r)-isomer
17. Propafenone Hydrochloride, (s)-isomer
18. Propafenone, (+-)-isomer
19. Propafenone, (r)-isomer
20. Propafenone, (s)-isomer
21. Propamerck
22. Rythmol
23. Rytmo-puren
24. Rytmogenat
25. Rytmonorm
26. Sa 79
27. Sa-79
28. Sa79
1. 34183-22-7
2. Propafenone Hcl
3. Rythmol
4. Rytmonorm
5. Arythmol
6. Pronon
7. Rythmol Sr
8. Propafenone (hydrochloride)
9. Propafenon Hydrochlorid
10. 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one Hydrochloride
11. Sa-79 (hydrochloride)
12. 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one Hydrochloride
13. 1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one Hydrochloride
14. 33xch0hocd
15. Nsc-758640
16. 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;hydrochloride
17. Mls000069682
18. Chebi:8466
19. Baxarytmon
20. Fenoprain
21. 2'-(2-hydroxy-3-(propylamino)propoxy)-3-phenylpropiophenone Hydrochloride
22. 1-propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, Hydrochloride
23. Rhythmonorm
24. Smr000058493
25. 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-1-propanone Hydrochloride
26. Sa 79
27. Propafenon Hydrochlorid [german]
28. Sr-01000000192
29. Einecs 251-867-9
30. Unii-33xch0hocd
31. Wz 884
32. Propafenone, Hcl
33. Prestwick_831
34. Rythmol (tn)
35. Mfcd00079243
36. Propafenone Hydrochloride [usan:usp:jan]
37. Opera_id_1835
38. Schembl41412
39. Mls001148185
40. Mls002222267
41. Spectrum1503935
42. Chembl1201063
43. Hy-b0432a
44. Dtxsid101017233
45. Hms1569d19
46. Hms1922m16
47. Pharmakon1600-01503935
48. Bcp28548
49. Tox21_500919
50. Ccg-39061
51. Nsc758640
52. Propafenone Hydrochloride [mi]
53. Akos008901409
54. Propafenone Hydrochloride (jp17/usp)
55. Ks-5030
56. Lp00919
57. Nsc 758640
58. Propafenone Hydrochloride [jan]
59. Propafenone Hydrochloride [usan]
60. Propiophenone, 2'-(2-hydroxy-3-(propylamino)propoxy)-3-phenyl-, Hydrochloride
61. Ncgc00094230-01
62. Ncgc00094230-02
63. Ncgc00094230-03
64. Ncgc00094230-04
65. Ncgc00094230-05
66. Ncgc00261604-01
67. Propafenone Hydrochloride [mart.]
68. Propafenone Hydrochloride [vandf]
69. Ac-11360
70. Ac-33196
71. Propafenone Hydrochloride [usp-rs]
72. Propafenone Hydrochloride [who-dd]
73. Db-048579
74. Eu-0100919
75. Ft-0630579
76. P2301
77. En300-51034
78. D00640
79. P 4670
80. Propafenone Hydrochloride [ep Monograph]
81. Propafenone Hydrochloride [orange Book]
82. Propafenone Hydrochloride [usp Monograph]
83. 183p227
84. A822113
85. J-019481
86. Sr-01000000192-2
87. Sr-01000000192-6
88. Q27108087
89. Z802671518
90. 1-(2-[2-hydroxy-3-(propylamino)propoxy]phenyl)-3-phenyl-1propanone
91. 2'-(2-hydroxy-3-propylaminopropoxy)-3-phenylpropiophenone Hydrochloride
92. Propafenone Hydrochloride, European Pharmacopoeia (ep) Reference Standard
93. 1-[2-[2-oxidanyl-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one Hydrochloride
94. 2-hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]-n-propylpropan-1-aminium Chloride
95. Hydron;1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one;chloride
96. Propafenone Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 377.9 g/mol |
---|---|
Molecular Formula | C21H28ClNO3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 11 |
Exact Mass | 377.1757714 g/mol |
Monoisotopic Mass | 377.1757714 g/mol |
Topological Polar Surface Area | 58.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 368 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Propafenone hydrochloride |
Drug Label | Propafenone hydrochloride is an antiarrhythmic drug supplied in scored, film-coated tablets of 150 and 225 mg for oral administration. Propafenone has some structural similarities to beta-blocking agents.Chemically, propafenone hydrochloride (HCl) is... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 150mg; 300mg; 225mg; 425mg; 325mg |
Market Status | Prescription |
Company | Vintage Pharms; Ani Pharms; Par Pharm; Watson Labs; Mutual Pharm |
2 of 6 | |
---|---|
Drug Name | Rythmol |
PubMed Health | Propafenone (By mouth) |
Drug Classes | Antiarrhythmic, Group IC |
Drug Label | RYTHMOL SR (propafenone hydrochloride) is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425mg for oral administration.Chemically, propafenone hydrochloride is 2-[2-Hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophe... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 150mg; 300mg; 225mg |
Market Status | Prescription |
Company | Glaxosmithkline |
3 of 6 | |
---|---|
Drug Name | Rythmol sr |
PubMed Health | Propafenone (By mouth) |
Drug Classes | Antiarrhythmic, Group IC |
Drug Label | RYTHMOL SR (propafenone hydrochloride) is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425mg for oral administration.Chemically, propafenone hydrochloride is 2-[2-Hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophe... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 225mg; 425mg; 325mg |
Market Status | Prescription |
Company | Glaxosmithkline |
4 of 6 | |
---|---|
Drug Name | Propafenone hydrochloride |
Drug Label | Propafenone hydrochloride is an antiarrhythmic drug supplied in scored, film-coated tablets of 150 and 225 mg for oral administration. Propafenone has some structural similarities to beta-blocking agents.Chemically, propafenone hydrochloride (HCl) is... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 150mg; 300mg; 225mg; 425mg; 325mg |
Market Status | Prescription |
Company | Vintage Pharms; Ani Pharms; Par Pharm; Watson Labs; Mutual Pharm |
5 of 6 | |
---|---|
Drug Name | Rythmol |
PubMed Health | Propafenone (By mouth) |
Drug Classes | Antiarrhythmic, Group IC |
Drug Label | RYTHMOL SR (propafenone hydrochloride) is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425mg for oral administration.Chemically, propafenone hydrochloride is 2-[2-Hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophe... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 150mg; 300mg; 225mg |
Market Status | Prescription |
Company | Glaxosmithkline |
6 of 6 | |
---|---|
Drug Name | Rythmol sr |
PubMed Health | Propafenone (By mouth) |
Drug Classes | Antiarrhythmic, Group IC |
Drug Label | RYTHMOL SR (propafenone hydrochloride) is an antiarrhythmic drug supplied in extended-release capsules of 225, 325 and 425mg for oral administration.Chemically, propafenone hydrochloride is 2-[2-Hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophe... |
Active Ingredient | Propafenone hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 225mg; 425mg; 325mg |
Market Status | Prescription |
Company | Glaxosmithkline |
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)